02.07.2021
Other
$509,266.00
30 months
COVID-19 vaccine responses in patients with Inflammatory Bowel Disease
Recently approved mRNA-based vaccines hold promise for protection against COVID-19, but studies are urgently needed to test their safety and efficacy in IBD patients who may be at increased risk of complications due to immune system dysfunction. This project will assess COVID-19 vaccines' efficacy, assess any adverse reactions, and identify variables that impact immune response in patients with IBD.